Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1175-1179

  Plouffe, J F ^a,f   Herbert, M T ^b   File Jr , T M ^c   Baird, I ^d   Parsons, J N ^b   Kahn, J B ^e   Rielly Gauvin, K T ^e   Best, M ^g   Dalieh, S ^g   Fass, R J ^g   Francis, S ^g   Gray, G ^g   Hackman, B A ^g   Koletar, S L ^g   Maher, W E ^g   Mazur, C ^g   Minor, J ^g   Oglevee, B A ^g   Para, M F ^g   Porterfield Baxa, J ^g   Rogers, T ^g   Saltrom, S J ^g   Sarokis, M ^g   Scott Tibbs, G ^g   Signs, D ^g   Stuart, D ^g   Tan, J ^g   Tumbleson, C S ^g   Walker, P ^g   more..

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Medical Education   (United States)

^c SUMMA HEALTH SYSTEM   (United States)

^d RIVERSIDE METHODIST HOSPITAL   (United States)

^e Ortho McNeil Pharmaceutical Incorporated   (United States)

^f Division of Infectious Diseases   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFTIZOXIME; CLAVULANIC ACID; ERYTHROMYCIN; MACROLIDE; OFLOXACIN; SULBACTAM; TICARCILLIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DRUG TOLERABILITY; EMPYEMA; FEMALE; GLOSSITIS; HAEMOPHILUS INFLUENZAE; HUMAN; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; NAUSEA; ORAL DRUG ADMINISTRATION; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VOMITING;

EID: 9244237536     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1175     Document Type: Article

References (27)

1. Ashby, B. L. 1991. Treatment of pneumonia: new strategies, for changing pathogens Clin. Ther 13:637-650.
2. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliot, and R. R. Facklam. 1994. Emergence of drug resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
3. Centers for Disease Control. 1994. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee. 1993. Morbid. Mortal. Week. Rep. 43: 23-25.
4. Cherubin, C. E., R. H. K. Eng, S. M. Smith, and E. N. Tan. 1992. A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other agents for respiratory pathogens. Diagn. Microbiol Infect. Dis. 15:141-144.
5. Cundell, D., R. Masure, and E. I. Tnomanen. 1995 The molecular basis of pneumococcal infection: a hypothesis. Clin. Infect. Dis. 21(Suppl. 3):S204-S212.
6. Edelstein, P. A. 1995. Antimicrobial chemotherapy for Legionairres' disease. a review. Clin. Infect. Dis. 21(Suppl. 3):S265-S276
7. Fine, M. J., D. E. Singer, B. H. Hanusa, J. R. Lave, and W. N. Kapoor. 1993. Validation of a pneumonia prognostic index using the MedisGroups comparative hospital database. Am J. Med. 94:153-159
8. Friedland, I. R., and G. H. McCracken. 1994. Management of infections caused by antibiotic resistant Streptococcus pneumoniae N. Engl J. Med. 331:377-382.
9. Gentry, L. O., B. Lipsky, M. O. Farber, B. Tucker, and G. Rodriguez-Gomez. 1992 Oral ofloxacin therapy for lower respiratory tract infections. South. Med. J. 85:14-18.
10. Gentry, L. O., G. Rodriguez-Gomez, R. B. Kohler, F. A. Kahn, and M. W. Rytel. 1992. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization. Am Rev. Rcspir. Dis. 145:31-35
11. Gleckman, R. A. 1994. Oral empirical treatment of pneumonia. Postgrad. Med. 95:165-172.
12. Grayston, J.T., V. K. Diwan, M. Cooney, and S. Wang. 1989. Community and hospital acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern. Med. 149:169-173.
13. Grayston, J. T., C.-C. Kuo, S.-P. Wang, and J. Altman. 1986 A new Chlamydia psittact strain, TWAR, isolated in acute respiratory tract infections. N. Engl J. Med. 315:161-168.
14. Grayston, J. T., C. Mordhorst, A. Bruu, S. Vene, and S. Wang. 1989 Countrywide epidemics of Chlamydia pneumoniae. strain TWAR, in Scandinavia, 1961-1983. J. Infect. Dis. 159:1111-1114
15. Håkansson, A., A. Kidd, G. Wadell, H. Sabharwal, and C. Svanborg. 1994. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect. Immun 62:2707-2714
16. Jorgensen, J. H., G. V. Doern, L. A. Maher, A. W. Howell, and J. S. Redding. 1990. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob. Agents Chemother. 34:2075-2080.
17. Kahn, J. B. 1996 Assessment of ofloxacin as a new therapeutic option in community acquired lower respiratory tract infections Infect. Med. 13:141-151
18. Lancet. 1991. Mycoplasma pneumoniae. Lancet 337:651-652 (Editorial.)
19. Lipsky, B. A., K. J. Tack, C. C. Kuo, S.-P. Wang, and J. T. Grayston. 1990. Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am. J. Med 89:722-724.
20. Lonks, J. R., and A. A. Medeiros. 1993 High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R. I. Antimicrob. Agents Chemother. 37: 1742-1745.
21. Macfarlane, J. T., A. Colville, A. Guion, R. M. Macfarlane, and D. H. Rose. 1993. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 341:511-515.
22. Marston, B., J. Plouffe, R. Breiman, T. File, R. Benson, L. Thacker, K. Wong, S. Skelton, B. Hackman, S. Salstrom, J. J. Barbaree, and CBPIS Group. 1991 Preliminary findings of a community-based pneumonia incidence study (CBPIS). abstr 55, p. 108. In Program and of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D C.
23. Niederman, M. S., J. B. Bass, Jr., G. D. Campbell, A. M. Fein, R. F. Grossman, L. A. Mandell, T. J. Marrie, G. A. Sarosi, A. Torres, and V. L. Yu. 1993. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy Am. Rev. Respir Dis 148:1418-1426
24. Plotowski, M.-C, E. Puchelle, G. Beck, J. Jacquot, and C. Hannoun. 1986. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus Am. Rev. Respir. Dis. 134:1040-1044.
25. Plouffe, J. F., R. F. Breiman, R. R. Facklam, et al. 1996. Bacteremia with Streptococcus pneumonia?: implications for therapy and prevention. JAMA 275:194-198.
26. Plouffe, J. F., T. M. File, R. F. Breiman, B. A. Hackman, S. J. Salstrom, B. J. Marston, B. S. Fields, and CBPIS Study Group. 1995. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Clin. Infect. Dis. 20:1286-1291.
27. Sanders, W. E., Jr., J. F. Morris, P. Alessi, A. T. Makris, et al. 1991 Oral ofloxacin for the treatment of acute bacterial pneumonia, use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial Am J Med 91:261-266.